ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,487,000 | +206.3% | 3,045,999 | +166.6% | 0.02% | +214.3% |
| Q4 2021 | $4,077,000 | +220.8% | 1,142,491 | +226.8% | 0.01% | +250.0% |
| Q3 2021 | $1,271,000 | +211.5% | 349,593 | +101.9% | 0.00% | +100.0% |
| Q1 2020 | $408,000 | +101.0% | 173,156 | +300.1% | 0.00% | – |
| Q4 2019 | $203,000 | +40.0% | 43,281 | 0.0% | 0.00% | – |
| Q3 2019 | $145,000 | -89.0% | 43,281 | -90.0% | 0.00% | -100.0% |
| Q1 2019 | $1,316,000 | -51.0% | 434,594 | -56.0% | 0.00% | -66.7% |
| Q4 2018 | $2,686,000 | -28.0% | 988,812 | -11.0% | 0.01% | -14.3% |
| Q3 2018 | $3,732,000 | +27.4% | 1,110,597 | -2.2% | 0.01% | +16.7% |
| Q2 2018 | $2,930,000 | +49.6% | 1,135,517 | +27.5% | 0.01% | +100.0% |
| Q1 2018 | $1,959,000 | – | 890,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |